Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers.
Rohrberg KS, Olesen RK, Pfeiffer P, Ladekarl M, Pappot H, Christensen IJ, Høyer-Hansen G, Sørensen M, Skov BG, Buysschaert I, Carmeliet P, Lassen U.
Rohrberg KS, et al. Among authors: sorensen m.
Acta Oncol. 2012 Feb;51(2):234-42. doi: 10.3109/0284186X.2011.619568. Epub 2011 Oct 21.
Acta Oncol. 2012.
PMID: 22017239
Clinical Trial.